Cabaletta Bio's (CABA) Buy Rating Reiterated at Guggenheim
Guggenheim reaffirmed their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Monday, Benzinga reports. They currently have a $34.00 target price on the stock. Separately, HC Wainwright upped their target price on shares of Cabaletta Bio from $15.00 to $17.00 and gave the company a buy […]